Full-Time

Project Coordination Associate

PSI CRO

PSI CRO

1,001-5,000 employees

Global CRO delivering on-time patient enrollment

No salary listed

No H1B Sponsorship

Durham, NC, USA

Hybrid

Hybrid role; requires 1 day on-site per week in Durham, NC.

Bachelor's

Category
Biology & Biotech (1)

Get referred to PSI CRO

See people who can refer or advise you

Requirements
  • College or university degree in Life Sciences or an equivalent combination of education, training and experience that presents the required knowledge, skills and abilities is considered sufficient.
  • Minimum four years of CRO and/or relevant clinical research experience required
  • Must be in a commutable distance to the office in Durham, NC
  • Strong communication and presentation skills
  • Attention to detail and organizational skills are critical
  • Ability to work in a team setting as well as independently as needed
  • Proficient in using Microsoft Office tools
Responsibilities
  • Ensures planning, implementation, and management of trials in compliance with industry regulations, ICH-GCP, essential trial records and applicable controlled documents (e.g., PSI QSDs or Sponsor QMS documents)
  • Ensures consistency of Clinical Operations processes in the assigned trials across the trial regions
  • Organizes the exchange of trial-specific information and records with sites, sponsors, and vendors
  • Participates in and follows up on regulatory and ethics committee submissions and notifications
  • Tracks the financial and contractual tasks within the project team
  • Supervises the preparation for and follow-up on site audits and inspections
  • Organizes, participates in and prepares reports of project meetings
  • Organizes, attends, and follows up on Investigator Meetings
  • Conducts on-the-job coaching of Site Management Associates and Clinical Operations Administrative Support staff
  • Coordinates and monitors compliance of trial-specific trainings of the project team
  • Supervises site and trial handovers between Site Management Associates Project Coordination Associate
  • Maintains and oversees the regular TMF quality checks for completeness and accuracy
  • Prepares for and follows up on system audits and inspections
  • Supervises the preparation, distribution, and update of ISFs and ISF checklists
  • Supervises the translation process for trial records on a regional and global level
  • Maintains and reviews trial-specific and corporate tracking management systems
  • Supervises the timely update of trial-specific and corporate tracking management systems done by the project team
  • Coordinates clinical supplies order, receipt, inventory, storage, distribution, return/recall, and reconciliation, and maintains accurate records of thereof
  • Drafts and tracks project plans
  • Initiates and supervises the trial-specific IP-REDs review process
  • Supervises performance of Site Management Associates
  • Performs other assigned trial coordination tasks as delegated by the Project Manage

PSI CRO is a global contract research organization that handles clinical trials for multiple therapeutic areas, with a focus on enrolling patients on schedule and delivering studies on time. Its services span feasibility assessments, trial planning, site selection, patient recruitment, and multi-continent trial execution across 50+ countries, backed by medical doctor resources dedicated to accurate timeline predictions. Unlike many CROs, PSI emphasizes predictable enrollment and on-time project delivery, aiming for high client satisfaction and repeat business through a pragmatic, no-nonsense approach. The company’s goal is to be regarded as the best CRO in the world by both clients and employees, achieved through reliable timelines, strong execution, and low staff turnover.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Switzerland

Founded

1995

Get referred to PSI CRO

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SYNETIC cuts site identification from six weeks to minutes, speeding sponsor startup decisions.
  • Mississauga office and Canada leadership expansion strengthen North American execution on pivotal phase II/III studies.
  • Japan, China, and Toronto expansions deepen local access while preserving PSI’s global operating model.

What critics are saying

  • SYNETIC depends on clean historical data; bad inputs poison site recommendations immediately.
  • China expansion raises exposure to regulators, data localization, and cross-border trial approvals in 2026.
  • PSI’s consultant-heavy CRO model faces attrition and margin pressure if recruitment quality slips.

What makes PSI CRO unique

  • SYNETIC launched January 29, 2026, combining site history across 62 countries and 3 million sites.
  • PSI opened Beijing April 28, 2026, positioning operations near Chinese regulators and institutions.
  • PSI hired heavily in 2026, with 254 open roles and 73 posted last month.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Wellness Program

Mental Health Support

Conference Attendance Budget

Professional Development Budget

Company News

PSI CRO
Apr 28th, 2026
From Shanghai to Beijing: PSI CRO expands its footprint in China with a new Beijing office.

From Shanghai to Beijing: PSI CRO expands its footprint in China with a new Beijing office. Beijing, China - April 28, 2026 - PSI CRO, a Swiss-based global full-service contract research organization, today announced the opening of its second office in China, located in China World Tower B in Beijing's Chaoyang District. In 2019, PSI established its first China office in Shanghai, where the local team has steadily grown while supporting sponsors across the region. By adding a Beijing location, PSI brings its team closer to key drug regulatory authorities and leading research institutions. China is playing an increasingly important role in global clinical development, creating a growing need for strong local operational and regulatory support. PSI's presence in Beijing helps meet that need, combining local expertise with coordinated global teams to support clear decision-making and predictable, on-time delivery for sponsors. For PSI, the Beijing office represents a targeted investment to support clients where it matters most - close to regulators, close to investigator sites, and close to strategic partners.

PR Newswire
Mar 19th, 2026
PSI cuts clinical trial site selection from 6 weeks to minutes with AI agent on Arango platform

PSI CRO, a global clinical research organisation, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC, an AI knowledge engine powered by the Arango Contextual Data Platform. The system helps identify higher-performing trial sites and minimise costly non-enrolling institutions, which account for 30-40% of trial sites. Clinical trials can cost over $160 per minute operationally, and activating a trial site costs $30,000 or more. With 15% of sites never enrolling a single patient, failed recruitment can cost millions per study. SYNETIC unifies fragmented clinical research data into a single contextual layer, preserving relationships across investigators, institutions, protocols and historical outcomes. The platform provides explainable AI recommendations, including rationale, supporting evidence and confidence levels, enabling data-driven site selection in minutes rather than weeks.

PharmiWeb
Jan 7th, 2026
PSI CRO Strengthens Canadian Presence with New Toronto Office and Leadership Role

PSI CRO strengthens Canadian presence with new Toronto office and leadership role. PSI CRO has broadened its footprint in Canada by opening a new office in the Toronto area and naming an experienced industry leader to guide its operations there. The office, located in Mississauga, Ontario, builds on the company's established Canadian presence and commitment to clinical research excellence. PSI CRO has been active in Canada for over a decade, supporting complex clinical trials with a focus on dependable delivery and strong relationships with research sites. As part of this expansion, David Allen, MBA, has been appointed as Country Manager for Canada. Allen brings more than 30 years of experience in clinical research from both sponsor and CRO environments. In his new role, he will lead efforts to enhance the company's operational capabilities in the local market and ensure alignment with PSI's global standards for on-time trial execution. PSI's continued growth in North America reflects broader trends of increasing trial activity in the region, particularly for pivotal phase II and phase III studies where precision and efficiency are critical. The expanded Toronto operations aim to further support sponsors with rigorous trial planning and execution.

PSI CRO
Mar 13th, 2025
PSI CRO Appoints Sayaka Kaji as Country Manager Japan

TOKYO, 14 March 2025 - PSI CRO AG, a global Swiss-based clinical research organization (CRO), is pleased to announce the appointment of Sayaka Kaji as Country Manager for Japan.

PSI CRO
Sep 6th, 2023
PSI FAQs: How does PSI reduce CRA staff turnover on your project?

Psi CRO Ag launched a CRA Academy to provide to help its team members develop therapeutic expertise as well as soft skills to manage key relationships with sites.